Compliance News | September 21, 2021
The IRS recently announced that the cost of an at-home COVID-19 test is an eligible medical expense. The cost is reimbursable from a health flexible spending account (FSA), health savings account (HSA), health reimbursement arrangement (HRA) or Archer medical savings account (MSA).
The IRS announcement on at-home COVID-19 tests also reminds taxpayers that other expenses related to COVID-19 are also reimbursable from health FSAs, HSAs, HRAs and Archer MSAs, including these:
We discussed that earlier IRS announcement on COVID-19-related PPE in our March 30, 2021 compliance insight.
Plan sponsors should determine what types of COVID-19-related personal protective equipment (PPE) and/or COVID-19 home testing their health plans will cover.
Plan sponsors should work with their plan administrator to determine what substantiation will be required for coverage of these items and communicate that information to plan participants.
In addition, plan sponsors should prepare to answer questions from participants about those expenses.
This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.
Don't miss out. Join 16,000 others who already get the latest insights from Segal.